Publications by authors named "Chakra Chaulagain"

Claim this Profile
D
Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses.
Laahn Foster, Larry D Anderson, Alfred Chung, Chakra P Chaulagain, Erin Pettijohn

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression to removal, an emerging therapeutic approach for AL amyloidosis: A comprehensive review with early human data and pharmacokinetics of CAEL-101 antibody.
Anam Ashfaque, Yara Shatnawi, Shahzad Raza, Diana Basali, Jack Khouri, Chakra Chaulagain

Blood Rev· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study.
Ashraf Badros, Laahn Foster, Larry D Anderson, Chakra P Chaulagain, Erin Pettijohn

Blood· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Real-World Analysis on Access to Triplet and Quadruplet Therapy in Newly Diagnosed Multiple Myeloma Patients in the United States.
Ludovic Saba, Chieh-Lin Fu, Hong Liang, Chakra P Chaulagain

Clin Lymphoma Myeloma Leuk· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How we manage multiple myeloma with clonal hematopoiesis of indeterminate potential (CHIP): a case report.
Ludovic Saba, Lewis Nasr, Jorge Manrique-Succar, Julia Diacovo, Chakra Chaulagain

Ann Transl Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and Emerging Immunotherapies for Systemic AL Amyloidosis.
Valeria Moreno, Ludovic Saba, Sara Tama-Shekan, Chakra P Chaulagain

Discov Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How We Treat Hemolytic Anemia Due to Pyruvate Kinase Deficiency.
Sara Tama-Shekan, Valeria Moreno, Ludovic Saba, Chakra P Chaulagain

Hematol Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating ChatGPT as an educational resource for patients with multiple myeloma: A preliminary investigation.
Ludovic Saba, Chieh-Lin Fu, Jack Khouri, Beth Faiman, Faiz Anwer, Chakra P Chaulagain

Am J Hematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world analysis on the determinants of survival in primary plasma cell leukemia in the United States.
Ludovic Saba, Kevin S Landau, Hong Liang, Chieh-Lin Fu, Chakra P Chaulagain

Leukemia· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy of Retreatment With Venetoclax-Based Therapy in Relapsed-Refractory t(11;14) Multiple Myeloma.
Danai Dima, Mark Orland, Fauzia Ullah, Faiz Anwer, Sandra Mazzoni, Chakra P Chaulagain

Clin Lymphoma Myeloma Leuk· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary Pure Red Cell Aplasia During Daratumumab/ Hyaluronidase Therapy for Multiple Myeloma.
Ludovic Saba, Kevin S Landau, Silvia Bunting, Chakra P Chaulagain

Oncology (Williston Park)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addendum: Systemic AL amyloidosis: current approach and future direction.
Maroun Bou Zerdan, Lewis Nasr, Farhan Khalid, Sabine Allam, Youssef Bouferraa, Chakra P Chaulagain

Oncotarget· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation Phase.
Hussein Awada, Adel Hajj Ali, Faiz Anwer, Raza Shahzad, Sandra Mazzoni, Chakra Chaulagain

Clin Appl Thromb Hemost· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On demand plerixafor is safe and effective for hematopoietic progenitor cell mobilization in patients with light chain amyloidosis at risk for mobilization failure with G-CSF alone.
Anne Hubben, Danai Dima, Tahani Atieh, Chakra Chaulagain, Beth Faiman

Bone Marrow Transplant· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid biopsies and minimal residual disease in myeloid malignancies.
Sabine Allam, Kristina Nasr, Farhan Khalid, Zunairah Shah, Mahammed Ziauddin Khan Suheb, Chakra P Chaulagain

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid biopsies and minimal residual disease in lymphoid malignancies.
Maroun Bou Zerdan, Joseph Kassab, Ludovic Saba, Elio Haroun, Morgan Bou Zerdan, Chakra P Chaulagain

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Relapsed-Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice.
Danai Dima, Fauzia Ullah, Sandra Mazzoni, Louis Williams, Beth Faiman, Chakra Chaulagain

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic AL amyloidosis: current approach and future direction.
Maroun Bou Zerdan, Lewis Nasr, Farhan Khalid, Sabine Allam, Youssef Bouferraa, Chakra P Chaulagain

Oncotarget· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances in the Treatment and Supportive Care of POEMS Syndrome.
Maroun Bou Zerdan, Tracy I George, Silvia Tse Bunting, Chakra P Chaulagain

J Clin Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology.
Maroun Bou Zerdan, Lewis Nasr, Ludovic Saba, Paul Meouchy, Nadine Safi, Chakra P Chaulagain

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidisciplinary supportive care in systemic light chain amyloidosis.
Bou Zerdan Maroun, Sabine Allam, Chakra P Chaulagain

Blood Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of ten-year overall survival of acute myeloid leukemia: a large national cancer database analysis.
Nabin Khanal, Valerie Shostrom, Prajwal Dhakal, Shristi Upadhyay Banskota, Chakra Chaulagain

Leuk Lymphoma· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adhesion molecules in multiple myeloma oncogenesis and targeted therapy.
Maroun Bou Zerdan, Lewis Nasr, Joseph Kassab, Ludovic Saba, Myriam Ghossein, Chakra P Chaulagain

Int J Hematol Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of Bruton's Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström's Macroglobulinemia).
Maroun Bou Zerdan, Jason Valent, Maria Julia Diacovo, Karl Theil, Chakra P Chaulagain

Adv Hematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges of Managing Multiple Myeloma Patients with Sickle Cell Disease: A Case Report and Review of Literature.
Maroun Bou Zerdan, Maria Julia Diacovo, Chakra P Chaulagain

Am J Case Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis